HB417Introduced in the House of Delegates
Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
Introduced by Jesse Pippy, District 4
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act
Where it stands
Motion Special Order until Next Session (Senator Love) Adopted
April 13, 2026
How did lawmakers vote?
House of DelegatesStage: Third Reading Passed · March 4, 2026
127
Yes
0
No
14
Absent or Not Voting
141 delegates recorded in this House of Delegates vote. Colors show vote categories only, not whether a vote was good or bad.
See how each delegate voted
| Delegate | District | Vote |
|---|---|---|
| Jason Buckel | 1 | Yes |
| Terry Baker | 1 | Yes |
| Jim Hinebaugh | 1 | Yes |
| William Wivell | 2 | Absent |
| William Valentine | 2 | Yes |
| Matthew Schindler | 2 | Yes |
| Ken Kerr | 3 | Yes |
| Kris Fair | 3 | Yes |
| Karen Simpson | 3 | Yes |
| Barrie Ciliberti | 4 | Yes |
Bill history
First Reading Health
Hearing 2/10 at 2:00 p.m.
Hearing canceled
Hearing 2/10 at 2:30 p.m.
Favorable with Amendments Report by Health
Favorable with Amendments {953328/1 Adopted
Second Reading Passed with Amendments
Third Reading Passed (127-0)
Referred Finance
Favorable Report by Finance
Favorable
Motion Special Order until Next Session (Senator Love) Adopted
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.